Hydrogen peroxide induces neurite degeneration: Prevention by tocotrienols

Free Radical Research

Volumn 45, Issue 6, 2011, Pages 681-691

  Fukui, Koji ^a,b,c   Takatsu, Hirokatsu ^d   Koike, Tatsuro ^c   Urano, Shiro ^a,b  

^a Department of Bioscience and Engineering   (Japan)

^b SHIBAURA INSTITUTE OF TECHNOLOGY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d University Industry Selangor   (Malaysia)

Author keywords

antioxidant; cell death; neurite; ROS; tocotrienolXS

Indexed keywords

ALPHA TOCOPHEROL; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; GAMMA TOCOTRIENOL; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; TOCOPHEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CEREBELLUM GRANULE CELL; CONTROLLED STUDY; DRUG EFFICACY; GRANULE CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN DENATURATION; PROTEIN LOCALIZATION; STRUCTURE ACTIVITY RELATION; TREATMENT RESPONSE; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CELL SHAPE; CELLS, CULTURED; HYDROGEN PEROXIDE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEURITES; OXIDANTS; OXIDATIVE STRESS; TOCOTRIENOLS;

EID: 79959425339     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.567984     Document Type: Article

References (43)

1. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291-295. (Pubitemid 27182306)
2. Fukui K, Omoi N, Hayasaka T, Shinkai T, Suzuki S, Abe K, Urano S. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann N Y Acad Sci 2002;959:275-284. (Pubitemid 34457568)
3. Brouwers O, Niessen PM, Ferreira I, Miyata T, Scheffer PG, Teerlink T, Schrauwen P, Brownlee M, Stehouwer CD, Schalkwijk CG. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J Biol Chem. 2011;288: 1374-1380.
4. Baydas G. Effects of vitamin E on the brain in diabetes. In: Preedy VR, Watson RR, editors. The Encyclopedia of vitamin E. CAB International; 2007. p. 487-493.
5. Cecchi C, Fiorillo C, Baglioni S, Pensalfini A, Bagnoli S, Nacmias B, Sorbi S, Nosi D, Relini A, Liguri G. Increased susceptibility to amyloid toxity in familial Alzheimer ' s Disease. Neurobiol Aging 2007;28:863-876. (Pubitemid 46589746)
6. Hadid LK, Lee MT, Yang J. Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity. J Biol Chem 2010;285: 38933-38943.
7. Ko SY, Lin YP, Lin YS, Chang SS. Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species. Free Radic Biol Med 2010;49:474-480.
8. Harman D. Aging; a theory based on free radical and radiation chemistry. J Gerontrol 1956;11:298-300.
9. Urano S, Sato Y, Otonari T, Makabe S, Suzuki S, Ogata M, Endo T. Aging and oxidative stress in neurodegeneration. Biofactors 1998;7:103-112. (Pubitemid 28073880)
10. Omoi NO, Arai M, Saito M, Takatsu H, Shibata A, Fukuzawa K, Sato K, Abe K, Fukui K, Urano S. Influence of oxidative stress on fusion of pre-synaptic plasma membranes of the rat brain with phosphatidyl choline liposomes, and protective effect of vitamin E. J Nutr Sci Vitaminol 2006;52:248-255. (Pubitemid 44520052)
11. Onodera K, Omoi NO, Fukui K, Hayasaka T, Shinkai T, Suzuki S, Abe K, Urano S. Oxidative damage of rat cerebral cortex and hippocampus, and changes in antioxidative defense systems caused by hyperoxia. Free Radic Res 2003;37:367-372. (Pubitemid 36240399)
12. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer ' s disease. The Alzheimer ' s disease cooperative study. N Engl J Med 1997;336:1216-1222. (Pubitemid 27183651)
13. Adolfsson O, Huber BT, Meydani SN. Vitamin Eenhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing Capacity. J Immunol 2001;167:3809-3817. (Pubitemid 32910826)
14. Azzi A, Ricciarelli R, Zingg JM. Non-antioxidant molecular functions of a-tocopherol (vitamin E). FEBS Lett 2002;519:8-10. (Pubitemid 34521983)
15. Fukui K, Onodera K, Shinkai T, Suzuki S, Urano S. Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems. Ann N Y Acad Sci 2001;928:168-175. (Pubitemid 32386078)
16. Fukui K, Takatsu H, Shinkai T, Suzuki S, Abe K, Urano S. Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress. J Alzheimers Dis 2005;8:299-309.
17. Kelly TA, Katagiri Y, Vartanian KB, Kumar P, Chen LL, Rosoff WJ, Urbach JS, Geller HM. Localized alteration of microtubule polymerization in response to guidance cues. J Neurosci Res 2010;88:3024-3033.
18. Touma E, Kato S, Fukui K, Koike T. Calpain-mediated cleavage of collapsing response mediator protein (CRMP)-2 during neurite degeneration in mice. Eur J Neurosci 2007; 26:3368-3381. (Pubitemid 350243516)
19. 2+ chelators cause ' dying-back ' neurite degeneration associated with energy impairment. J Neurosci Res 2007;85:2844-2855. (Pubitemid 47523568)
20. Wang LH, Strimatter SM. A family of rat CRMP genes is differentially expressed in the nervous system. J Neurosci 1996;16:6197-6207.
21. Fukata Y, Itoh T, Kimura T, Manager C, Nishimura T, Shiromizu T, Watanabe H, Inagaki N, Iwamatsu A, Hotani H, Kaibuchi K. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 2002;4: 583-591.
22. Yuasa-Kawada J, Suzuki R, Kano F, Ohkawara T, Murata M, Noda M. Axonal morphologenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. Eur J Neurosci 2003;17:2329-2343. (Pubitemid 36793742)
23. Yoshida H, Watanabe A, Ihara Y. Collapsin response mediator protein-2 is associated with neurofi brillary tangles in Alzheimer ' s disease. J Biol Chem 1998;273:9761-9768. (Pubitemid 28183069)
24. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, Nakamura F, Takei K, Ihara Y, Mikoshiba K, Kolattukudy P, Honnorat J, Goshima Y. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3 phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes cells 2005; 10: 165-179. (Pubitemid 40287519)
25. Cole AR, Noble W, van Aalten L, Plattner F, Meimaridou R, Hogan D, Taylor M, LaFrancois J, Gunn-Moore F, Verkhratsky A, Oddo S, LaFerla F, Giese KP, Dineley KT, Duff K, Richardson JC, Yan SD, Hanger DP, Allan SM, Sutherland C. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer ' s disease progression. J Neurochem 2007;103:1132-1144. (Pubitemid 47568734)
26. Petratos S, Li QX, George AJ, Hou X, Kerr ML, Unabia SE, Hatzinisiriou I, Maksel D, Aguilar MI, Small DH. The β-amyloid protein of Alzheimer ' s disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 2008;131:90-108.
27. Wada S. Chemoprevention of tocotrienols: the mechanism of antiproliferative effects. Forum Nutr Basel Karger 2009;61: 204-216.
28. Srivastava JK, Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 2006; 346:447-453. (Pubitemid 43902706)
29. Yap WN, Zaiden N, Tan YL, Ngoh CP, Zhang XW, Wong YC, Ling MT, Yap YL. Id1, inhibitor of differentiation, is a key protein mediating anti-tumor or responses of gamma-tocotrienol in breast cancer cells. Cancer Lett 2010;291:187-199.
30. He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo . J Nutr 1997;127:668-674. (Pubitemid 27200738)
31. Miyazawa T, Shibata A, Sookwong P, Kawakami Y, Eitsuka T, Asai A, Oikawa S, Nakagawa K. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol). J Nutri Biochem 2009;20:79-86.
32. Khanna S, Roy S, Ryu H, Bahadduri P, Swaan PW, Ratan RR, Sen CK. Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamateinduced neurodegeneration. J Biol Chem 2003;278:43508-43515. (Pubitemid 37345974)
33. Suzuki K, Koike T. Brain-derived neurotrophic factor suppress programmed death of cerebellar granule cells through a posttranslational mechanism. Mol Chem Neuropathol 1997;30:101-124. (Pubitemid 27091961)
34. Ikegami K, Koike T. Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience 2003;122:617-626. (Pubitemid 37410283)
35. Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: optimization of critical parameters affecting calciumphosphate precipitate formation. Nucleic Acids Res 1996;24: 596-601. (Pubitemid 26085833)
36. Kamata T, Subleski M, Hara Y, Yuhki N, Kung H, Copeland NG, Jenkins NA, Yoshimura T, Modi W, Copeland TD. Isolation and characterization of a bovine neuronal specifi c protein (CRMP-2) cDNA homologous to unc-33, a C elegans gene implicated in axonal outgrowth and guidance. Mol Brain Res 1998;54:219-236. (Pubitemid 28171786)
37. Yamada KM, Spooner BS, Wessells NK. Axon growth: roles of microfi laments and microtubules. Proc Natl Acad Sci USA 1970;66:1206-1212.
38. Poulain EE, Sobel A. The microtubule network and neuronal morphogenesis: dynamics and coordinated orchestration through multiple players. Mol Cell Neurosci 2010;43: 15-32.
39. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 1993;268: 11230-11238. (Pubitemid 23162316)
40. Gu Y, Ihara Y. Evidence that collapsing response mediator protein-2 is involved in the dynamics of microtubules. J Biol Chem 2000;275:17917-17920. (Pubitemid 30414732)
41. Inagaki N, Chihara K, Arimura N, Menager C, Kawano Y, Matsuo N, Nishimura T, Amano M, Kaibuchi K. CRMP-2 induces axons in cultured hippocampal neurons. Nature Neurosci 2001;4:781-782. (Pubitemid 32702507)
42. Seet RC, Lee CY, Lim EC, Tan JJ, Quek AM, Chong WL, Looi WF, Huang SH, Wang H, Chan YH, Halliwell B. Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radic Biol Med 2010;48:560-566.
43. Tahimic CG, Tomimatsu N, Nishigaki K, Fukuhara A, Toda T, Kaibuchi K, Shiota G, Oshimura M, Kurimasa A. Evidence for a role of collapsing response mediator protein-2 in signaling pathways that regulate the proliferation of non-neuronal cells. Biochem Biophys Res Commun 2006;340:1244-1250. (Pubitemid 43083411)